Chordate Medical
Chordate Medical terminates the liquidity provider agreement for the preference share
Chordate Medical hereby announces that the company has terminated the agreement with Lago Kapital regarding the assignment as liquidity provider for the preference share CMH Pref.
The purpose of the liquidity provider has been to promote the liquidity of the company's preference share, reduce volatility and facilitate trading. Chordate Medical assesses that the current trading and liquidity in the share is good and that the benefit of the liquidity provider is limited.
The liquidity guarantee expires on 2025-06-17.
Datum | 2025-05-07, kl 10:55 |
Källa | MFN |
